• Top Picks
    • Personalized Medicine in Obesity Treatment: An In-depth Look at How to Use Today's Obesity Medications in Patients Who Need to Lose Weight
    • Improving Outcomes with SGLT2 Cotransporter Inhibitors in Challenging T2DM Patients: Updates from EASD 2013
    • Dialogues in Diabetes: Volume 3, Number 4
    • Obesity and Comorbidities: Improving Clinical Management and Patient Outcomes in Obesity and Asthma

Select a Topic

  • FILTER BY:
  • All Education Lab
  • CME Only
Experts’ Take: Dialogue on Hypertriglyceridemia
CME

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Expiration Date: 7/21/2015
Credit Type(s): CME | Credit: 0.75

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis. This has serious consequences, as the National Health and Nutrition Examination…

go to activity»
Acromegaly: Challenges in Diagnosis - Part 2 of 5
CME

Acromegaly: Challenges in Diagnosis - Part 2 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 4/24/2015
Credit Type(s): CME | Credit: 0.5

The diagnosis of acromegaly is often not made until 7 to 10 years after symptom onset. Contributing factors include low disease awareness among health care professionals as well as confusion with…

go to activity»
Treatment of Acromegaly: Current Options - Part 3 of 5
CME

Treatment of Acromegaly: Current Options - Part 3 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 4/24/2015
Credit Type(s): CME | Credit: 0.5

The goals of treatment for patients with acromegaly include controlling growth hormone excess, and relieving signs and complications of the disease. This article discusses the risks and benefits of…

go to activity»
Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5
CME

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 5/26/2015
Credit Type(s): CME | Credit: 0.5

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is associated with multiple comorbidities and increased mortality. However, diagnosis and…

go to activity»
Acromegaly: Pathophysiology, Signs,  Symptoms, and Complications - Part 1 of 5
CME

Acromegaly: Pathophysiology, Signs, Symptoms, and Complications - Part 1 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 4/24/2015
Credit Type(s): CME | Credit: 0.5

An understanding of the pathophysiological mechanisms of acromegaly is important to its various complications as well as its diagnosis and treatment. This article provides a succinct summary of the…

go to activity»
Treatment of Acromegaly: Emerging Options - Part 4 of 5
CME

Treatment of Acromegaly: Emerging Options - Part 4 of 5

This activity is supported by an educational grant from Genentech.

Expiration Date: 4/24/2015
Credit Type(s): CME | Credit: 0.5

Several medical therapies for acromegaly, including somatostatin receptor agonists, dopamine receptor agonists, and a growth hormone receptor antagonist, have become available in the past several…

go to activity»